Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001262620 | SCV001440557 | pathogenic | Autosomal recessive congenital ichthyosis 3 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002282503 | SCV002570928 | pathogenic | Lamellar ichthyosis | 2022-07-20 | criteria provided, single submitter | clinical testing | Variant summary: ALOXE3 c.680+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4e-06 in 251492 control chromosomes (gnomAD). c.680+1G>A has been reported in the literature in two homozygous individuals affected with congenital ichthyoses (Hotz_2021 and Mohamad_2021). These data indicate that the variant is very likely to be associated with disease. Two submitters provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Institute for Human Genetics, |
RCV001262620 | SCV001477362 | pathogenic | Autosomal recessive congenital ichthyosis 3 | 2021-01-07 | no assertion criteria provided | clinical testing |